<DOC>
	<DOCNO>NCT01303536</DOCNO>
	<brief_summary>The aim study evaluate whether ondansetron augmentation SSRI improve ondansetron discontinuation result worsen obsessive compulsive symptom among obsessive compulsive disorder resistant patient .</brief_summary>
	<brief_title>Ondansetron Augmentation Treatment-resistant OCD</brief_title>
	<detailed_description />
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>diagnosis OCD establish clinical interview license psychiatrist ; score ≥ 24 Yale Brown Obsessive Compulsive Scale Clinical Global Inventory score ≥ 4 , 12 week treatment adequate trial selective serotonin reuptake inhibitor moderate high dose diagnosis schizophrenia , schizoaffective disorder , organic mental disorder , bipolar disorder , current substance dependence abuse , current major depressive episode precede onset obsessive compulsive disorder undergo concomitant behavior therapy significant cardiovascular , hepatic , renal pulmonary disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>